CHYM SEC Filings
SEC filings for CHYM. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 4Britt Christopher RChief Executive Officer | Oct 17, 2026 | 0002061801-26-000021EDGAR |
| 4King Ryan ACo-Founder | Oct 17, 2026 | 0002061219-26-000021EDGAR |
| 4King Ryan ACo-Founder | Oct 13, 2026 | 0002061219-26-000019EDGAR |
| 4DST Global Advisors Ltd | Sep 17, 2026 | 0001193125-26-393444EDGAR |
| 4DST Managers VII Ltd | Sep 17, 2026 | 0001193125-26-393439EDGAR |
| 4Feuille James | Sep 16, 2026 | 0001318214-26-000009EDGAR |
| 4FRANKEL ADAM BGeneral Counsel | Sep 16, 2026 | 0001241526-26-000021EDGAR |
| 4DST Managers VII Ltd | Sep 16, 2026 | 0001193125-26-392296EDGAR |
| 4King Ryan ACo-Founder | Sep 15, 2026 | 0002061219-26-000017EDGAR |
| 4Britt Christopher RChief Executive Officer | Sep 15, 2026 | 0002061801-26-000019EDGAR |
| 4CAROLAN SHAWN T | Sep 15, 2026 | 0001376066-26-000007EDGAR |
| 4Feuille James | Sep 14, 2026 | 0001318214-26-000006EDGAR |
| 4Marshall Cynthia | Sep 14, 2026 | 0001820725-26-000006EDGAR |
| 8-K | Sep 8, 2026 | 0001193125-26-385383EDGAR |
| SC 13GMSOP GP, L.L.C. and 10 other reporting persons | Aug 10, 2026 | 0001705785-26-000007EDGAR |
| 10-QAIChime's MD&A reports strong year-over-year growth in revenue, Active Members and profitability, and a swing to net income after the IPO-related stock compensation charge in the prior year. | Aug 6, 2026 | 0001795586-26-000048EDGAR |
| 8-K | Aug 5, 2026 | 0001795586-26-000046EDGAR |
| 8-K | Jun 4, 2026 | 0001795586-26-000042EDGAR |
| SC 13G/AamendedMSOP GP, L.L.C. and 10 other reporting persons | May 15, 2026 | 0001705785-26-000004EDGAR |
| SC 13G/AamendedMichael J. Stark and 1 other reporting person | May 15, 2026 | 0001104329-26-000007EDGAR |
| 10-QAIChime's Q1 2026 MD&A is upbeat and factual, highlighting 25% revenue growth, a swing to $53.5 million net income, adjusted EBITDA margin expansion from 5% to 18%, and lower transaction losses. | May 7, 2026 | 0001795586-26-000038EDGAR |
| 8-K | May 6, 2026 | 0001795586-26-000035EDGAR |
| DEF 14A | Apr 17, 2026 | 0001795586-26-000028EDGAR |
| 10-K | Mar 6, 2026 | 0001795586-26-000013EDGAR |
| 8-K | Feb 25, 2026 | 0001795586-26-000004EDGAR |
| 8-KAIChime Financial announced the appointment of Mark Troughton, previously Chief Operating Officer, as President effective December 8, 2025. | Dec 10, 2025 | 0001795586-25-000023EDGAR |
| SC 13GGeneral Atlantic, L.P and 13 other reporting persons | Nov 10, 2025 | 0000950142-25-002934EDGAR |
| 10-Q | Nov 10, 2025 | 0001795586-25-000019EDGAR |
| 8-K | Nov 5, 2025 | 0001795586-25-000015EDGAR |
SEC filings for companies related to CHYM
Never miss a CHYM filing.
Get an email when CHYM files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.